Literature DB >> 18242473

To add amiodarone or not: that is the question.

Matthew Jason Zimmerman, Myron C Gerson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242473     DOI: 10.1016/j.nuclcard.2007.10.003

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  28 in total

Review 1.  The effects of amiodarone on the thyroid.

Authors:  E Martino; L Bartalena; F Bogazzi; L E Braverman
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

Authors:  Myron C Gerson; Laura L Craft; Nancy McGuire; Damodhar P Suresh; William T Abraham; Lynne E Wagoner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

3.  Stereoselective effect of amiodarone on the pharmacokinetics of racemic carvedilol.

Authors:  Kyoko Fukumoto; Takashi Kobayashi; Kazuo Komamura; Shiro Kamakura; Masafumi Kitakaze; Kazuyuki Ueno
Journal:  Drug Metab Pharmacokinet       Date:  2005-12       Impact factor: 3.614

4.  Combination therapy with carvedilol and amiodarone in patients with severe heart failure.

Authors:  H Nägele; M Bohlmann; U Eck; B Petersen; W Rödiger
Journal:  Eur J Heart Fail       Date:  2000-03       Impact factor: 15.534

5.  Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.

Authors:  B M Massie; S G Fisher; M Radford; P C Deedwania; B N Singh; R D Fletcher; S N Singh
Journal:  Circulation       Date:  1996-06-15       Impact factor: 29.690

6.  Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects.

Authors:  L B Mitchell; D G Wyse; A M Gillis; H J Duff
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

7.  Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.

Authors:  G E Newton; J H Tong; A M Schofield; A D Baines; J S Floras; J D Parker
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

8.  The effect of amiodarone on the beta-adrenergic receptor is due to a downregulation of receptor protein and not to a receptor-ligand interaction.

Authors:  V Drvota; J Häggblad; I Blange; Y Magnusson; S Sylvén
Journal:  Biochem Biophys Res Commun       Date:  1999-02-16       Impact factor: 3.575

9.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

10.  Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy.

Authors:  Myron C Gerson; Nancy McGuire; Lynne E Wagoner
Journal:  J Card Fail       Date:  2003-10       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.